The markers were glioma stem cell markers (CD133 and Msh1), neuronal lineage markers (nestin, sox1, sox2, and pax6), and differentiated markers (GFAP, Tuj1, and Olig123). The gene discussed is NES; the disease is central nervous system cancer.